Detalhe da pesquisa
1.
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma.
Mol Ther Oncolytics
; 30: 167-180, 2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674626
2.
Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Clin Transl Immunology
; 10(5): e1283, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33976881
3.
Erratum: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma.
Clin Transl Immunology
; 10(7): e1317, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34295472